These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 22086139)

  • 21. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?
    Howlett DR; Richardson JC
    Histol Histopathol; 2009 Jan; 24(1):83-100. PubMed ID: 19012248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerating Alzheimer's research through 'natural' animal models.
    Braidy N; Poljak A; Jayasena T; Mansour H; Inestrosa NC; Sachdev PS
    Curr Opin Psychiatry; 2015 Mar; 28(2):155-64. PubMed ID: 25602247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic mouse models for APP processing and Alzheimer's disease: early and late defects.
    van Dooren T; Dewachter I; Borghgraef P; van Leuven F
    Subcell Biochem; 2005; 38():45-63. PubMed ID: 15709472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Animal models of Alzheimer's disease: therapeutic implications.
    Woodruff-Pak DS
    J Alzheimers Dis; 2008 Dec; 15(4):507-21. PubMed ID: 19096153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early-onset and robust amyloid pathology in a new homozygous mouse model of Alzheimer's disease.
    Willuweit A; Velden J; Godemann R; Manook A; Jetzek F; Tintrup H; Kauselmann G; Zevnik B; Henriksen G; Drzezga A; Pohlner J; Schoor M; Kemp JA; von der Kammer H
    PLoS One; 2009 Nov; 4(11):e7931. PubMed ID: 19936202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
    Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative insults to neurons and synapse are prevented by aged garlic extract and S-allyl-L-cysteine treatment in the neuronal culture and APP-Tg mouse model.
    Ray B; Chauhan NB; Lahiri DK
    J Neurochem; 2011 May; 117(3):388-402. PubMed ID: 21166677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
    Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
    Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.
    Wang QH; Wang YR; Zhang T; Jiao SS; Liu YH; Zeng F; Li J; Yao XQ; Zhou HD; Zhou XF; Wang YJ
    J Neurochem; 2016 Jul; 138(1):163-73. PubMed ID: 26991827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model.
    Jin WS; Shen LL; Bu XL; Zhang WW; Chen SH; Huang ZL; Xiong JX; Gao CY; Dong Z; He YN; Hu ZA; Zhou HD; Song W; Zhou XF; Wang YZ; Wang YJ
    Acta Neuropathol; 2017 Aug; 134(2):207-220. PubMed ID: 28477083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review.
    Ahmad SS; Khan S; Kamal MA; Wasi U
    CNS Neurol Disord Drug Targets; 2019; 18(9):657-667. PubMed ID: 31608840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascidians: an invertebrate chordate model to study Alzheimer's disease pathogenesis.
    Virata MJ; Zeller RW
    Dis Model Mech; 2010; 3(5-6):377-85. PubMed ID: 20197417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model.
    Ju Y; Tam KY
    Neuropharmacology; 2020 Dec; 181():108354. PubMed ID: 33035533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease.
    Hunter JM; Bowers WJ; Maarouf CL; Mastrangelo MA; Daugs ID; Kokjohn TA; Kalback WM; Luehrs DC; Valla J; Beach TG; Roher AE
    J Alzheimers Dis; 2011; 27(2):361-76. PubMed ID: 21860086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ structural characterization of early amyloid aggregates in Alzheimer's disease transgenic mice and Octodon degus.
    Benseny-Cases N; Álvarez-Marimon E; Aso E; Carmona M; Klementieva O; Appelhans D; Ferrer I; Cladera J
    Sci Rep; 2020 Apr; 10(1):5888. PubMed ID: 32246090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.
    Suh YH; Checler F
    Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.